Immunomodulatory therapy for pediatric inflammatory bowel disease: Changing patterns of use, 1990-2000

American Journal of Gastroenterology

Volumn 97, Issue 4, 2002, Pages 928-932

  Markowitz, James ^a   Grancher, Kathy ^a   Kohn, Nina ^a,b   Daum, Fredric ^a  

^a North Shore LIJ Health System ^*  (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOMODULATING AGENT; MERCAPTOPURINE; METHOTREXATE; MYCOPHENOLIC ACID; TACROLIMUS;

ANUS FISTULA; ARTICLE; COLON RESECTION; ENTERITIS; GROWTH DISORDER; HEALTH SURVEY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; RECURRENT DISEASE;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; AGE FACTORS; ATTITUDE OF HEALTH PERSONNEL; CHILD; CHILD, PRESCHOOL; GASTROENTEROLOGY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; TIME FACTORS;

EID: 0036117776     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)03967-9     Document Type: Article

References (36)

1. Azathioprine and 6-mercaptopurine in Crohn disease: A meta-analysis
2. A review of immune modifier therapy for inflammatory bowel disease: Azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate
3. Long-term 6-mercaptopurine in treatment of adolescents with Crohn's disease
4. 6-Mercaptopurine therapy in selected cases of corticosteroid-dependent Crohn's disease
5. Azathioprine in the treatment of children with inflammatory bowel disease
6. Use of azathioprine in nine children with Crohn's disease
7. Cyclosporine as an alternative to surgery in children with inflammatory bowel disease
8. Cyclosporine for the treatment of fulminant ulcerative colitis in children
9. Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflammatory bowel disease
10. Cyclosporine and 6-mercaptopurine for active, refractory Crohn's colitis in children
11. Tacrolimus (FK-506) treatment of fulminant colitis in a child
12. Methotrexate in patients with Crohn's disease after 6-mercaptopurine
13. Experiences with 6-mercaptopurine and azathioprine therapy on pediatric patients with severe ulcerative colitis
14. Immunosuppressive therapy in pediatric inflammatory bowel disease: Results of a survey of the North American Society for Gastroenterology and Nutrition
15. Inflammatory bowel diseases with onset in childhood. Clinical features, morbidity and mortality in a regional cohort
16. Clinical outcome of ulcerative colitis in children
17. Population-based study of surgery in juvenile onset Crohn's disease
18. Quality of life in children with Crohn's disease
19. Morbidity of juvenile onset inflammatory bowel disease: Effects on education and employment in early adult life
20. Growth and development in chronic inflammatory bowel disease
21. Growth impairment in pediatric inflammatory bowel disease
22. 6-Mercaptopurine in the management of inflammatory bowel disease: Shortand long-term toxicity
23. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease
24. Controlled trial of azathioprine in Crohn's disease
25. Controlled trial of azathioprine in Crohn's disease
26. Treatment of Crohn's disease with azathioprine: A controlled evaluation
27. A controlled trial of azathioprine in Crohn's disease
28. Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease
29. Introduction of 6-mercaptopurine in Crohn's disease patients during the perioperative period: A preliminary evaluation of recurrence of disease
30. Azathioprine and 6-mercaptopurine for the treatment of perianal Crohn's disease in children
31. A multicenter trial of 6-mercaptopurine and prednisone in newly diagnosed children with Crohn's disease
32. Post-operative prophylaxis with 6-MP, 5-ASA or placebo in Crohn's disease. A two-year multicenter trial
33. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs
34. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment
35. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease
36. Review article: The risks of malignancy from either immunosuppression or diagnostic radiation in inflammatory bowel disease